ESMO 2018 | Defining risk profiles of endometrial cancer

Carien Creutzberg

Carien Creutzberg, MD, PhD, of the Leiden University Medical Center, Leiden, Netherlands, discusses the findings of the PORTEC-2 trial (NCT00376844) and explores current aims of the PORTEC-4 trial (NCT03469674) as well. This trials seek to compare brachytherapy versus external beam radiation, among other treatments, between patients exhibiting different molecular profiles of endometrial cancer, with the hope that it will lead to better-targeted therapies. This video was recorded at the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany.

Share this video